Orchestra BioMed Holdings, Inc. (OBIO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

47.75M
Year ended 2025-12-31
+47.1%
3-year compound annual growth
2021-12-31: 20.45M2022-12-31: 14.99M2023-12-31: 33.23M2024-12-31: 36.82M2025-12-31: 47.75M47.75M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3147.75M+29.7%2026-03-12, From 2025-01-01
2024-12-3136.82M+10.8%2026-03-12, From 2024-01-01
2023-12-3133.23M+121.7%2025-03-31, From 2023-01-01
2022-12-3114.99Mn/c2024-03-27, From 2022-01-01
2021-12-3120.45Mn/a2023-01-25, From 2021-01-01